Wei‐Yu Chen
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 5
- MicroRNA in disease regulation 4
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 4
- Molecular Biology top 10%
- Cancer-related gene regulation 5
- Wnt/β-catenin signaling in development and cancer 4
- Dermatology top 5%
-
- Prostate Cancer Treatment and Research 19
-
- Cancer, Stress, Anesthesia, and Immune Response 6
Wei‐Yu Chen
76 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 480
- Oncology 397
- Molecular Biology 989
- Dermatology 119
- Pulmonary and Respiratory Medicine 423
Countries citing papers authored by Wei‐Yu Chen
This map shows the geographic impact of Wei‐Yu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Yu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Yu Chen more than expected).
Fields of papers citing papers by Wei‐Yu Chen
This network shows the impact of papers produced by Wei‐Yu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Yu Chen. The network helps show where Wei‐Yu Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei‐Yu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 14 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 38 | |
| 8 | 2021 | 22 | |
| 9 | 2019 | 39 | |
| 10 | 2018 | 47 | |
| 11 | 2017 | 48 | |
| 12 | 2017 | 18 | |
| 13 | 2016 | 132 | |
| 14 | 2016 | 10 | |
| 15 | 2015 | 96 | |
| 16 | 2014 | 19 | |
| 17 | 2013 | 1 | |
| 18 | 2013 | 28 | |
| 19 | 2013 | 17 | |
| 20 | 2011 | 14 |
About Wei‐Yu Chen
Wei‐Yu Chen is a scholar working on Cancer Research, Dermatology and Pulmonary and Respiratory Medicine, having authored 80 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (19 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers), Cancer-related gene regulation (5 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), MicroRNA in disease regulation (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Cancer Research (480 citations), Oncology (397 citations) and Molecular Biology (989 citations). Wei‐Yu Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Yen‐Nien Liu, Jiaoti Huang, Juan Juan Yin, Yung-Sheng Chang, Yu‐Jia Chang, Wen‐Ying Liao, Chung‐Chi Hsu, Kelvin K. Tsai, Tze‐Sian Chan and Michael Hsiao. Their work appears in journals such as Neuron, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.